{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:11:17Z","timestamp":1791205877176,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T00:00:00Z","timestamp":1282003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2407-10-433","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T18:14:56Z","timestamp":1283364896000},"source":"Crossref","is-referenced-by-count":98,"title":["Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models"],"prefix":"10.1186","volume":"10","author":[{"given":"Siver A","family":"Moestue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrid","family":"Borgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else M","family":"Huuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evita M","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beathe","family":"Sitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"B\u00f8rresen-Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Engebraaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild M","family":"M\u00e6landsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid S","family":"Gribbestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,17]]},"reference":[{"key":"2232_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, et al: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038\/35021093.","journal-title":"Nature"},{"key":"2232_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073\/pnas.0932692100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2232_CR4","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/bcr1517","volume":"8","author":"S Calza","year":"2006","unstructured":"Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, et al: Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006, 8: R34-10.1186\/bcr1517.","journal-title":"Breast Cancer Res"},{"issue":"Suppl 2","key":"2232_CR5","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.breast.2007.07.017","volume":"16","author":"J Kurebayashi","year":"2007","unstructured":"Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, et al: The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast. 2007, 16 (Suppl 2): S72-S77. 10.1016\/j.breast.2007.07.017.","journal-title":"Breast"},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1373\/clinchem.2006.083725","volume":"53","author":"M Mullins","year":"2007","unstructured":"Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, et al: Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. Clin Chem. 2007, 53: 1273-1279. 10.1373\/clinchem.2006.083725.","journal-title":"Clin Chem"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1471-2164-7-127","volume":"7","author":"T Sorlie","year":"2006","unstructured":"Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, et al: Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics. 2006, 7: 127-10.1186\/1471-2164-7-127.","journal-title":"BMC Genomics"},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.05.004","volume":"69","author":"ZK Stadler","year":"2009","unstructured":"Stadler ZK, Come SE: Review of gene-expression profiling and its clinical use in breast cancer. Crit Rev Oncol Hematol. 2009, 69: 1-11. 10.1016\/j.critrevonc.2008.05.004.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2174\/156800908786733432","volume":"8","author":"M Banez-Coronel","year":"2008","unstructured":"Banez-Coronel M, de Molina AR, Rodriguez-Gonzalez A, Sarmentero J, Ramos MA, Garcia-Cabezas MA, et al: Choline kinase alpha depletion selectively kills tumoral cells. Curr Cancer Drug Targets. 2008, 8: 709-719. 10.2174\/156800908786733432.","journal-title":"Curr Cancer Drug Targets"},{"key":"2232_CR10","first-page":"3112","volume":"59","author":"R Hernandez-Alcoceba","year":"1999","unstructured":"Hernandez-Alcoceba R, Fernandez F, Lacal JC: In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. Cancer Res. 1999, 59: 3112-3118.","journal-title":"Cancer Res"},{"key":"2232_CR11","first-page":"419","volume":"4","author":"JC Lacal","year":"2001","unstructured":"Lacal JC: Choline kinase: a novel target for antitumor drugs. IDrugs. 2001, 4: 419-426.","journal-title":"IDrugs"},{"key":"2232_CR12","doi-asserted-by":"publisher","first-page":"8803","DOI":"10.1038\/sj.onc.1207062","volume":"22","author":"A Rodriguez-Gonzalez","year":"2003","unstructured":"Rodriguez-Gonzalez A, Ramirez de MA, Fernandez F, Ramos MA, del Carmen NM, Campos J, et al: Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells. Oncogene. 2003, 22: 8803-8812. 10.1038\/sj.onc.1207062.","journal-title":"Oncogene"},{"key":"2232_CR13","first-page":"999","volume":"26","author":"A Rodriguez-Gonzalez","year":"2005","unstructured":"Rodriguez-Gonzalez A, Ramirez de MA, Banez-Coronel M, Megias D, Lacal JC: Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism. Int J Oncol. 2005, 26: 999-1008.","journal-title":"Int J Oncol"},{"key":"2232_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12282-008-0048-x","volume":"15","author":"M Tozaki","year":"2008","unstructured":"Tozaki M: Proton MR spectroscopy of the breast. Breast Cancer. 2008, 15: 218-223. 10.1007\/s12282-008-0048-x.","journal-title":"Breast Cancer"},{"key":"2232_CR15","first-page":"80","volume":"59","author":"EO Aboagye","year":"1999","unstructured":"Aboagye EO, Bhujwalla ZM: Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 1999, 59: 80-84.","journal-title":"Cancer Res"},{"key":"2232_CR16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/ijc.22293","volume":"120","author":"G Eliyahu","year":"2007","unstructured":"Eliyahu G, Kreizman T, Degani H: Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer. 2007, 120: 1721-1730. 10.1002\/ijc.22293.","journal-title":"Int J Cancer"},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-03-3829","volume":"64","author":"K Glunde","year":"2004","unstructured":"Glunde K, Jie C, Bhujwalla ZM: Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res. 2004, 64: 4270-4276. 10.1158\/0008-5472.CAN-03-3829.","journal-title":"Cancer Res"},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.bioeng.7.060804.100411","volume":"7","author":"RJ Gillies","year":"2005","unstructured":"Gillies RJ, Morse DL: In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005, 7: 287-326. 10.1146\/annurev.bioeng.7.060804.100411.","journal-title":"Annu Rev Biomed Eng"},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1148\/radiology.204.3.9280241","volume":"204","author":"WB Mackinnon","year":"1997","unstructured":"Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, et al: Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology. 1997, 204: 661-666.","journal-title":"Radiology"},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/nbm.1940050518","volume":"5","author":"W Negendank","year":"1992","unstructured":"Negendank W: Studies of human tumors by MRS: a review. NMR Biomed. 1992, 5: 303-324.","journal-title":"NMR Biomed"},{"key":"2232_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/nbm.992","volume":"19","author":"B Sitter","year":"2006","unstructured":"Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS: Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006, 19: 30-40. 10.1002\/nbm.992.","journal-title":"NMR Biomed"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1148\/radiol.2332031285","volume":"233","author":"S Meisamy","year":"2004","unstructured":"Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, et al: Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. Radiology. 2004, 233: 424-431. 10.1148\/radiol.2332031285.","journal-title":"Radiology"},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/mrm.21333","volume":"58","author":"DL Morse","year":"2007","unstructured":"Morse DL, Raghunand N, Sadarangani P, Murthi S, Job C, Day S, et al: Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts. Magn Reson Med. 2007, 58: 270-280. 10.1002\/mrm.21333.","journal-title":"Magn Reson Med"},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0167-4889(90)90219-4","volume":"1052","author":"M Neeman","year":"1990","unstructured":"Neeman M, Eldar H, Rushkin E, Degani H: Chemotherapy-induced changes in the energetics of human breast cancer cells; 31P- and 13C-NMR studies. Biochim Biophys Acta. 1990, 1052: 255-263. 10.1016\/0167-4889(90)90219-4.","journal-title":"Biochim Biophys Acta"},{"key":"2232_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1593\/neo.06187","volume":"8","author":"K Glunde","year":"2006","unstructured":"Glunde K, Jie C, Bhujwalla ZM: Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia. 2006, 8: 758-771. 10.1593\/neo.06187.","journal-title":"Neoplasia"},{"key":"2232_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/nbm.1318","volume":"22","author":"DL Morse","year":"2009","unstructured":"Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, et al: Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed. 2009, 22: 114-127. 10.1002\/nbm.1318.","journal-title":"NMR Biomed"},{"key":"2232_CR27","first-page":"1966","volume":"62","author":"R Katz-Brull","year":"2002","unstructured":"Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H: Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res. 2002, 62: 1966-1970.","journal-title":"Cancer Res"},{"key":"2232_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrc2193","volume":"7","author":"T Vargo-Gogola","year":"2007","unstructured":"Vargo-Gogola T, Rosen JM: Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007, 7: 659-672. 10.1038\/nrc2193.","journal-title":"Nat Rev Cancer"},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molonc.2009.07.003","volume":"3","author":"A Bergamaschi","year":"2009","unstructured":"Bergamaschi A, Hjortland GO, Triulzi T, Sorlie T, Johnsen H, Ree AH, et al: Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Mol Oncol. 2009, 3: 469-482. 10.1016\/j.molonc.2009.07.003.","journal-title":"Mol Oncol"},{"key":"2232_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/nbm.775","volume":"15","author":"B Sitter","year":"2002","unstructured":"Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS: High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002, 15: 327-337. 10.1002\/nbm.775.","journal-title":"NMR Biomed"},{"key":"2232_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/nbm.1478","volume":"23","author":"B Sitter","year":"2010","unstructured":"Sitter B, Bathen TF, Singstad TE, Fjosne HE, Lundgren S, Halgunset J, et al: Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed. 2010, 23: 424-431.","journal-title":"NMR Biomed"},{"key":"2232_CR32","volume-title":"Stat Appl Genet Mol Biol","author":"GK Smyth","year":"2004","unstructured":"Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3"},{"key":"2232_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"key":"2232_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mrm.1157","volume":"46","author":"R Katz-Brull","year":"2001","unstructured":"Katz-Brull R, Margalit R, Degani H: Differential routing of choline in implanted breast cancer and normal organs. Magn Reson Med. 2001, 46: 31-38. 10.1002\/mrm.1157.","journal-title":"Magn Reson Med"},{"key":"2232_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/153537020623100503","volume":"231","author":"V Michel","year":"2006","unstructured":"Michel V, Yuan Z, Ramsubir S, Bakovic M: Choline transport for phospholipid synthesis. Exp Biol Med (Maywood). 2006, 231: 490-504.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2232_CR36","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1073\/pnas.0805496105","volume":"105","author":"M Gallazzini","year":"2008","unstructured":"Gallazzini M, Ferraris JD, Burg MB: GDPD5 is a glycerophosphocholine phosphodiesterase that osmotically regulates the osmoprotective organic osmolyte GPC. Proc Natl Acad Sci USA. 2008, 105: 11026-11031. 10.1073\/pnas.0805496105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2232_CR37","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr1771","volume":"9","author":"B Kreike","year":"2007","unstructured":"Kreike B, van KM, Horlings H, Weigelt B, Peterse H, Bartelink H, et al: Gene expression profiling and histopathological characterization of triple-negative\/basal-like breast carcinomas. Breast Cancer Res. 2007, 9: R65-10.1186\/bcr1771.","journal-title":"Breast Cancer Res"},{"key":"2232_CR38","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","volume":"40","author":"T Sorlie","year":"2004","unstructured":"Sorlie T: Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer. 2004, 40: 2667-2675. 10.1016\/j.ejca.2004.08.021.","journal-title":"Eur J Cancer"},{"key":"2232_CR39","first-page":"444","volume":"2","author":"R Bhargava","year":"2009","unstructured":"Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G, et al: Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers. Int J Clin Exp Pathol. 2009, 2: 444-455.","journal-title":"Int J Clin Exp Pathol"},{"key":"2232_CR40","first-page":"1375","volume":"16","author":"R Katz-Brull","year":"1996","unstructured":"Katz-Brull R, Degani H: Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 1996, 16: 1375-1380.","journal-title":"Anticancer Res"},{"key":"2232_CR41","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-04-3703","volume":"64","author":"MA Ramirez de","year":"2004","unstructured":"Ramirez de MA, Banez-Coronel M, Gutierrez R, Rodriguez-Gonzalez A, Olmeda D, Megias D, et al: Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res. 2004, 64: 6732-6739. 10.1158\/0008-5472.CAN-04-0489.","journal-title":"Cancer Res"},{"key":"2232_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/nbm.1940070405","volume":"7","author":"IS Gribbestad","year":"1994","unstructured":"Gribbestad IS, Petersen SB, Fjosne HE, Kvinnsland S, Krane J: 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 1994, 7: 181-194. 10.1002\/nbm.1940070405.","journal-title":"NMR Biomed"},{"key":"2232_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0","volume":"10","author":"KA Kvistad","year":"1999","unstructured":"Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE, et al: Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging. 1999, 10: 159-164. 10.1002\/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0.","journal-title":"J Magn Reson Imaging"},{"key":"2232_CR44","volume-title":"Proc Intl Soc Mag Reson Med","author":"G Eliyahu","year":"2007","unstructured":"Eliyahu G, Maril N, Margalit R, Degani H: Choline Metabolism in Breast Cancer; The Influence of the Microenvironmental conditions [Abstract]. Proc Intl Soc Mag Reson Med. 2007, 15:"},{"key":"2232_CR45","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1021\/pr9008783","volume":"9","author":"GF Giskeodegard","year":"2010","unstructured":"Giskeodegard GF, Grinde MT, Sitter B, Axelson DE, Lundgren S, Fjosne HE, et al: Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. J Proteome Res. 2010, 9: 972-979. 10.1021\/pr9008783.","journal-title":"J Proteome Res"},{"key":"2232_CR46","first-page":"2310","volume":"17","author":"N Mori","year":"2009","unstructured":"Mori N, Glunde K, Takagi T, Xiong L, Wides F, Bhujwalla Z: Tumor microenvironmental alterations of lipid metabolism detected by comparing cancer cells with tumors [Abstract]. Proc Intl Soc Mag Reson Med. 2009, 17: 2310-","journal-title":"Proc Intl Soc Mag Reson Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-433\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T22:09:30Z","timestamp":1636322970000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,17]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-433","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,17]]},"article-number":"433"}}